CONSTITUTIVE ACTIVATION OF PHOTOTRANSDUCTION BY K296E OPSIN IS NOT A CAUSE OF PHOTORECEPTOR DEGENERATION

被引:113
作者
LI, TS
FRANSON, WK
GORDON, JW
BERSON, EL
DRYJA, TP
机构
[1] HARVARD UNIV, MASSACHUSETTS EYE & EAR INFIRM, SCH MED, HOWE LAB OPHTHALMOL, BOSTON, MA 02114 USA
[2] CUNY MT SINAI SCH MED, DEPT OBSTET & GYNECOL, NEW YORK, NY 10029 USA
关键词
D O I
10.1073/pnas.92.8.3551
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The missense mutation Lys-296 --> Glu (K296E) in the rhodopsin gene produces an opsin with no chromophore binding site and therefore is not activated by light. Nevertheless, the mutant opsin constitutively activates transducin in vitro and causes photoreceptor degeneration in vivo, possibly by continuously activating the phototransduction cascade, analogous to constant exposure to environmental light. We studied the K296E mutation in eight lines of transgenic mice. Each line developed photoreceptor degeneration with the rate of degeneration increasing monotonically as the ratio of mutant:wild-type opsin mRNA increased. At no time in the course of degeneration was there endogenous light adaptation in the retina as measured by the electroretinogram. The mutant opsin was found to be invariably phosphorylated and stably bound to arrestin. Light-independent activation of transducin was demonstrated only after the removal of arrestin and dephosphorylation of K296E opsin, Thus, K296E opsin in vivo does not activate the phototransduction cascade because it is shut off by photoreceptor inactivation mechanisms, Our data show that the K296E mutation does not cause photoreceptor degeneration by continuous activation of phototransduction.
引用
收藏
页码:3551 / 3555
页数:5
相关论文
共 34 条
  • [1] Fain G.L., Lisman J.E., Exp. Eye Res., 57, pp. 335-340, (1993)
  • [2] LaVail M.M., The Effects of Constant Light on Visual Processes, pp. 357-387, (1980)
  • [3] Rapp L.M., Williams T.P., The Effects of Constant Light on Visual Processes, pp. 135-159, (1980)
  • [4] Fain G.L., Cornwall M.C., Contrast Sensitivity: From Receptors to Clinic, pp. 3-32, (1993)
  • [5] Keen T.J., Inglehearn C.F., Lester D.H., Bashir R., Jay M., Bird A.C., Jay B., Bhattacharya S.S., Genomics, 11, pp. 199-205, (1991)
  • [6] Robinson P.R., Cohen G.B., Zhukovsky E.A., Oprian D.D., Neuron, 9, pp. 719-725, (1992)
  • [7] Olsson J.E., Gordon J.W., Pawlyk B.S., Roof D., Hayes A., Molday R.S., Mukai S., Cowley G.S., Berson E.L., Dryja T.P., Neuron, 9, pp. 815-830, (1992)
  • [8] Gordon J.W., Scangos G.A., Plotkin D.J., Barbosa J.A., Ruddle F.H., Proc. Natl. Acad. Sci. USA, 77, pp. 7380-7384, (1980)
  • [9] Roof D., Hayes A., Hardenberg G., Adamian M., Invest. Ophthalmol. Visual Sci., 32, pp. 582-593, (1991)
  • [10] Hodges R.S., Heaton R.J., Parker J.M., Molday L., Molday R.S., J. Biol. Chem., 263, pp. 11768-11775, (1988)